Guo Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Guo Zhang has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Jian Jing
State Key Laboratory of Pharmaceutical Biotechnology, Department of Neurology and Medical Psychology, Nanjing Drum Tower Hospital, The affiliated Hospital of Nanjing University Medical School, Institute for Brain Sciences, Collaborative Innovation Center of Advanced Microstructures, School of Life Sciences, Nanjing University
11 shared publications Xue-Ying Ding
State Key Laboratory of Pharmaceutical Biotechnology, Department of Neurology and Medical Psychology, Nanjing Drum Tower Hospital, The affiliated Hospital of Nanjing University Medical School, Institute for Brain Sciences, Collaborative Innovation Center of Advanced Microstructures, School of Life Sciences, Nanjing University
8 shared publicationsJu-Ping Xu
State Key Laboratory of Pharmaceutical Biotechnology, Department of Neurology and Medical Psychology, Nanjing Drum Tower Hospital, The affiliated Hospital of Nanjing University Medical School, Institute for Brain Sciences, Collaborative Innovation Center of Advanced Microstructures, School of Life Sciences, Nanjing University
7 shared publicationsCheng-Yi Liu
State Key Laboratory of Pharmaceutical Biotechnology, Department of Neurology and Medical Psychology, Nanjing Drum Tower Hospital, The affiliated Hospital of Nanjing University Medical School, Institute for Brain Sciences, Collaborative Innovation Center of Advanced Microstructures, School of Life Sciences, Nanjing University
6 shared publicationsCui-Ping Liu
State Key Laboratory of Pharmaceutical Biotechnology, Department of Neurology and Medical Psychology, Nanjing Drum Tower Hospital, The affiliated Hospital of Nanjing University Medical School, Institute for Brain Sciences, Collaborative Innovation Center of Advanced Microstructures, School of Life Sciences, Nanjing University
6 shared publicationsHui-Ying Wang
State Key Laboratory of Pharmaceutical Biotechnology, Department of Neurology and Medical Psychology, Nanjing Drum Tower Hospital, The affiliated Hospital of Nanjing University Medical School, Institute for Brain Sciences, Collaborative Innovation Center of Advanced Microstructures, School of Life Sciences, Nanjing University
6 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 15
Distal conformational steering by N-terminal pyroglutamylation enables subtype-selective GPCR activation across Aplysia PRXamide and human Neuromedin U signaling
Post-translational modifications (PTMs) diversify neuropeptide function, yet how minimal modifications encode receptor specificity without direct contact remains a fundamental challenge in chemical biology. Pyroglutamylation (pQ), a prevalent N-terminal PTM in bioactive peptides, introduces a rigid cyclic constraint, yet its mechanistic role in receptor signaling is unclear. Here, using two newly identified endogenous Aplysia PRXamide receptors (ApPRXa R1 and ApPRXa-R2) as a model system, we find that the same ligand, MMG2-pDPb (pQPPLPRYamide), produces opposite functional outcomes: pQ suppresses ApPRXa-R1 activation while enhancing ApPRXa-R2 activation. In vitro and in silico analyses demonstrate that the N-terminal pQ/Q remains solvent-exposed and does not directly contact receptor residues. Instead, pQ reshapes the ligand conformational ensemble and redistributes interaction networks across shared receptor contact sites. Strikingly, this molecular logic extends to mammalian Neuromedin U (NmU) receptors, as canine NmU (pQFLFRPRNamide) similarly biases subtype preference of human NmU receptors. Both static and dynamic analyses further reveal that receptor pocket mechanics determine the direction of this modulation: a loose and permissive pocket better accommodates the rigid pQ-constrained ligand, whereas a more compact pocket favors the non-pyroglutamylated ligand. These findings define a “PTM distal steering” mechanism that bridges “lock-key” and “induced-fit” paradigms and establish a general principle by which a minimal, non-contacting modification encodes receptor preference through ligand conformational biasing and pocket-dependent permissiveness, providing a chemical framework for optimizing stable, conformation-biased neuropeptide analogs.
- 29 September 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 15
Open AccessDistal conformational steering by N-terminal pyroglutamylation enables subtype-selective GPCR activation across Aplysia PRXamide and human Neuromedin U signaling
Post-translational modifications (PTMs) diversify neuropeptide function, yet how minimal modifications encode receptor specificity without direct contact remains a fundamental challenge in chemical biology. Pyroglutamylation (pQ), a prevalent N-terminal PTM in bioactive peptides, introduces a rigid cyclic constraint, yet its mechanistic role in receptor signaling is unclear. Here, using two newly identified endogenous Aplysia PRXamide receptors (ApPRXa R1 and ApPRXa-R2) as a model system, we find that the same ligand, MMG2-pDPb (pQPPLPRYamide), produces opposite functional outcomes: pQ suppresses ApPRXa-R1 activation while enhancing ApPRXa-R2 activation. In vitro and in silico analyses demonstrate that the N-terminal pQ/Q remains solvent-exposed and does not directly contact receptor residues. Instead, pQ reshapes the ligand conformational ensemble and redistributes interaction networks across shared receptor contact sites. Strikingly, this molecular logic extends to mammalian Neuromedin U (NmU) receptors, as canine NmU (pQFLFRPRNamide) similarly biases subtype preference of human NmU receptors. Both static and dynamic analyses further reveal that receptor pocket mechanics determine the direction of this modulation: a loose and permissive pocket better accommodates the rigid pQ-constrained ligand, whereas a more compact pocket favors the non-pyroglutamylated ligand. These findings define a “PTM distal steering” mechanism that bridges “lock-key” and “induced-fit” paradigms and establish a general principle by which a minimal, non-contacting modification encodes receptor preference through ligand conformational biasing and pocket-dependent permissiveness, providing a chemical framework for optimizing stable, conformation-biased neuropeptide analogs.
- Open Access
- 13 July 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (9) , 113327
Decoding of amidated aromatic C-terminus and sulfation by cholecystokinin receptors reveals conserved and divergent evolutionary mechanisms
- 13 July 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (9) , 113327
Open AccessDecoding of amidated aromatic C-terminus and sulfation by cholecystokinin receptors reveals conserved and divergent evolutionary mechanisms
- Open Access
- 5 February 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (3) , 111257
A brain-gut excitatory peptide/CCHamide homolog regulates satiation and motivational state transitions in the Aplysia feeding circuit
- 5 February 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (3) , 111257
Open AccessA brain-gut excitatory peptide/CCHamide homolog regulates satiation and motivational state transitions in the Aplysia feeding circuit
- Open Access
- 22 September 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (39) , 45073-45089
Identification of a G Protein-Coupled Receptor for Buccalin-Type Peptides in the Mollusk Aplysia: Evolutionary Insights into Neuropeptide Signaling
Neuropeptides play a crucial role in modulating behavior, with certain signaling systems, such as those for Neuropeptide Y and Cholecystokinin (CCK), being clearly conserved across protostomes and deuterostomes. However, evolutionary relationships for other signaling systems are less evident. Buccalin (Buc) and allatostatin A (AstA) were independently discovered in the mollusk Aplysia californica and the arthropod Diploptera punctate and are now recognized as homologous. These peptides share a conserved C-terminal Y/F-X-F-G-L/I-amide motif. Bioinformatic evidence further suggests homology between this signaling system and the deuterostome galanin (GAL) and kisspeptin (KISS) signaling systems. Nonetheless, uncertainties persist, particularly due to the limited characterization of Buc/AstA receptors in lophotrochozoans, the superphylum that encompasses mollusks and annelids. To date, only one AstA receptor has been experimentally characterized in the annelid Platynereis dumerilii, while no receptors have been characterized in Aplysia. In this study, we combined bioinformatics, molecular biology, and a cell-based assay to identify an Aplysia buccalin receptor, designated as apBuc/AstA-R. The 19 mature buccalin peptides encoded by the buccalin precursor activated apBuc/AstA-R in a dose-dependent manner, with EC50 values ranging from 23 to 320 nM. Importantly, the potencies of buccalin A and B corresponded to their previously characterized physiological effects. To assess cross-activity, we tested whether Drosophila AstAs and human KISS/GAL can activate apBuc/AstA-R. While receptor activation was observed with Drosophila AstAs and human KISS, human GAL was not active. Phylogenetic and chromosomal gene analyses reinforced the idea that the protostome Buc/AstA signaling system is orthologous to the deuterostome GAL systems and paralogous with the KISS system. Additionally, bioinformatic data suggest the presence of a KISSR-like receptor in Aplysia, though it was not activated by either human KISS/GAL or by Aplysia and Drosophila Buc/AstAs. Overall, our study provides the first comprehensive characterization of the Buc/AstA signaling system in Aplysia and provides further evidence for its close evolutionary relationship with the deuterostome GAL and KISS signaling systems.
- 22 September 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (39) , 45073-45089
Open AccessIdentification of a G Protein-Coupled Receptor for Buccalin-Type Peptides in the Mollusk Aplysia: Evolutionary Insights into Neuropeptide Signaling
Neuropeptides play a crucial role in modulating behavior, with certain signaling systems, such as those for Neuropeptide Y and Cholecystokinin (CCK), being clearly conserved across protostomes and deuterostomes. However, evolutionary relationships for other signaling systems are less evident. Buccalin (Buc) and allatostatin A (AstA) were independently discovered in the mollusk Aplysia californica and the arthropod Diploptera punctate and are now recognized as homologous. These peptides share a conserved C-terminal Y/F-X-F-G-L/I-amide motif. Bioinformatic evidence further suggests homology between this signaling system and the deuterostome galanin (GAL) and kisspeptin (KISS) signaling systems. Nonetheless, uncertainties persist, particularly due to the limited characterization of Buc/AstA receptors in lophotrochozoans, the superphylum that encompasses mollusks and annelids. To date, only one AstA receptor has been experimentally characterized in the annelid Platynereis dumerilii, while no receptors have been characterized in Aplysia. In this study, we combined bioinformatics, molecular biology, and a cell-based assay to identify an Aplysia buccalin receptor, designated as apBuc/AstA-R. The 19 mature buccalin peptides encoded by the buccalin precursor activated apBuc/AstA-R in a dose-dependent manner, with EC50 values ranging from 23 to 320 nM. Importantly, the potencies of buccalin A and B corresponded to their previously characterized physiological effects. To assess cross-activity, we tested whether Drosophila AstAs and human KISS/GAL can activate apBuc/AstA-R. While receptor activation was observed with Drosophila AstAs and human KISS, human GAL was not active. Phylogenetic and chromosomal gene analyses reinforced the idea that the protostome Buc/AstA signaling system is orthologous to the deuterostome GAL systems and paralogous with the KISS system. Additionally, bioinformatic data suggest the presence of a KISSR-like receptor in Aplysia, though it was not activated by either human KISS/GAL or by Aplysia and Drosophila Buc/AstAs. Overall, our study provides the first comprehensive characterization of the Buc/AstA signaling system in Aplysia and provides further evidence for its close evolutionary relationship with the deuterostome GAL and KISS signaling systems.
- Open Access
- 11 July 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (8) , 107556
Two C-terminal isoforms of Aplysia tachykinin–related peptide receptors exhibit phosphorylation-dependent and phosphorylation-independent desensitization mechanisms
- 11 July 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (8) , 107556
Open AccessTwo C-terminal isoforms of Aplysia tachykinin–related peptide receptors exhibit phosphorylation-dependent and phosphorylation-independent desensitization mechanisms
- Open Access
- 11 May 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-17
Identification of three elevenin receptors and roles of elevenin disulfide bond and residues in receptor activation in Aplysia californica
Neuropeptides are ubiquitous intercellular signaling molecules in the CNS and play diverse roles in modulating physiological functions by acting on specific G-protein coupled receptors (GPCRs). Among them, the elevenin signaling system is now believed to be present primarily in protostomes. Although elevenin was first identified from the L11 neuron of the abdominal ganglion in mollusc Aplysia californica, no receptors have been described in Aplysia, nor in any other molluscs. Here, using two elevenin receptors in annelid Platynereis dumerilii, we found three putative elevenin GPCRs in Aplysia. We cloned the three receptors and tentatively named them apElevR1, apElevR2, and apElevR3. Using an inositol monophosphate (IP1) accumulation assay, we demonstrated that Aplysia elevenin with the disulfide bond activated the three putative receptors with low EC50 values (ranging from 1.2 to 25 nM), supporting that they are true receptors for elevenin. In contrast, elevenin without the disulfide bond could not activate the receptors, indicating that the disulfide bond is required for receptor activity. Using alanine substitution of individual conserved residues other than the two cysteines, we showed that these residues appear to be critical to receptor activity, and the three different receptors had different sensitivities to the single residue substitution. Finally, we examined the roles of those residues outside the disulfide bond ring by removing these residues and found that they also appeared to be important to receptor activity. Thus, our study provides an important basis for further study of the functions of elevenin and its receptors in Aplysia and other molluscs.
- 11 May 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-17
Open AccessIdentification of three elevenin receptors and roles of elevenin disulfide bond and residues in receptor activation in Aplysia californica
Neuropeptides are ubiquitous intercellular signaling molecules in the CNS and play diverse roles in modulating physiological functions by acting on specific G-protein coupled receptors (GPCRs). Among them, the elevenin signaling system is now believed to be present primarily in protostomes. Although elevenin was first identified from the L11 neuron of the abdominal ganglion in mollusc Aplysia californica, no receptors have been described in Aplysia, nor in any other molluscs. Here, using two elevenin receptors in annelid Platynereis dumerilii, we found three putative elevenin GPCRs in Aplysia. We cloned the three receptors and tentatively named them apElevR1, apElevR2, and apElevR3. Using an inositol monophosphate (IP1) accumulation assay, we demonstrated that Aplysia elevenin with the disulfide bond activated the three putative receptors with low EC50 values (ranging from 1.2 to 25 nM), supporting that they are true receptors for elevenin. In contrast, elevenin without the disulfide bond could not activate the receptors, indicating that the disulfide bond is required for receptor activity. Using alanine substitution of individual conserved residues other than the two cysteines, we showed that these residues appear to be critical to receptor activity, and the three different receptors had different sensitivities to the single residue substitution. Finally, we examined the roles of those residues outside the disulfide bond ring by removing these residues and found that they also appeared to be important to receptor activity. Thus, our study provides an important basis for further study of the functions of elevenin and its receptors in Aplysia and other molluscs.
- Open Access
- 20 March 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1132066
Characterization of an Aplysia vasotocin signaling system and actions of posttranslational modifications and individual residues of the ligand on receptor activity
The vasopressin/oxytocin signaling system is present in both protostomes and deuterostomes and plays various physiological roles. Although there were reports for both vasopressin-like peptides and receptors in mollusc Lymnaea and Octopus, no precursor or receptors have been described in mollusc Aplysia. Here, through bioinformatics, molecular and cellular biology, we identified both the precursor and two receptors for Aplysia vasopressin-like peptide, which we named Aplysia vasotocin (apVT). The precursor provides evidence for the exact sequence of apVT, which is identical to conopressin G from cone snail venom, and contains 9 amino acids, with two cysteines at position 1 and 6, similar to nearly all vasopressin-like peptides. Through inositol monophosphate (IP1) accumulation assay, we demonstrated that two of the three putative receptors we cloned from Aplysia cDNA are true receptors for apVT. We named the two receptors as apVTR1 and apVTR2. We then determined the roles of post-translational modifications (PTMs) of apVT, i.e., the disulfide bond between two cysteines and the C-terminal amidation on receptor activity. Both the disulfide bond and amidation were critical for the activation of the two receptors. Cross-activity with conopressin S, annetocin from an annelid, and vertebrate oxytocin showed that although all three ligands can activate both receptors, the potency of these peptides differed depending on their residue variations from apVT. We, therefore, tested the roles of each residue through alanine substitution and found that each substitution could reduce the potency of the peptide analog, and substitution of the residues within the disulfide bond tended to have a larger impact on receptor activity than the substitution of those outside the bond. Moreover, the two receptors had different sensitivities to the PTMs and single residue substitutions. Thus, we have characterized the Aplysia vasotocin signaling system and showed how the PTMs and individual residues in the ligand contributed to receptor activity.
- 20 March 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1132066
Open AccessCharacterization of an Aplysia vasotocin signaling system and actions of posttranslational modifications and individual residues of the ligand on receptor activity
The vasopressin/oxytocin signaling system is present in both protostomes and deuterostomes and plays various physiological roles. Although there were reports for both vasopressin-like peptides and receptors in mollusc Lymnaea and Octopus, no precursor or receptors have been described in mollusc Aplysia. Here, through bioinformatics, molecular and cellular biology, we identified both the precursor and two receptors for Aplysia vasopressin-like peptide, which we named Aplysia vasotocin (apVT). The precursor provides evidence for the exact sequence of apVT, which is identical to conopressin G from cone snail venom, and contains 9 amino acids, with two cysteines at position 1 and 6, similar to nearly all vasopressin-like peptides. Through inositol monophosphate (IP1) accumulation assay, we demonstrated that two of the three putative receptors we cloned from Aplysia cDNA are true receptors for apVT. We named the two receptors as apVTR1 and apVTR2. We then determined the roles of post-translational modifications (PTMs) of apVT, i.e., the disulfide bond between two cysteines and the C-terminal amidation on receptor activity. Both the disulfide bond and amidation were critical for the activation of the two receptors. Cross-activity with conopressin S, annetocin from an annelid, and vertebrate oxytocin showed that although all three ligands can activate both receptors, the potency of these peptides differed depending on their residue variations from apVT. We, therefore, tested the roles of each residue through alanine substitution and found that each substitution could reduce the potency of the peptide analog, and substitution of the residues within the disulfide bond tended to have a larger impact on receptor activity than the substitution of those outside the bond. Moreover, the two receptors had different sensitivities to the PTMs and single residue substitutions. Thus, we have characterized the Aplysia vasotocin signaling system and showed how the PTMs and individual residues in the ligand contributed to receptor activity.
- Open Access
- 30 August 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (10) , 102440
AI protein structure prediction-based modeling and mutagenesis of a protostome receptor and peptide ligands reveal key residues for their interaction
- 30 August 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (10) , 102440
Open AccessAI protein structure prediction-based modeling and mutagenesis of a protostome receptor and peptide ligands reveal key residues for their interaction
- Open Access
- 24 January 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-13
Identification of an allatostatin C signaling system in mollusc Aplysia
Neuropeptides, as pervasive intercellular signaling molecules in the CNS, modulate a variety of behavioral systems in both protostomes and deuterostomes. Allatostatins are neuropeptides in arthropods that inhibit the biosynthesis of juvenile hormones. Based on amino acid sequences, they are divided into three different types in arthropods: allatostatin A, allatostatin B, allatostatin C. Allatostatin C (AstC) was first isolated from Manduca sexta, and it has an important conserved feature of a disulfide bridge formed by two cysteine residues. Moreover, AstC appears to be the ortholog of mammalian somatostatin, and it has functions in common with somatostatin, such as modulating feeding behaviors. The AstC signaling system has been widely studied in arthropods, but minimally studied in molluscs. In this study, we seek to identify the AstC signaling system in the marine mollusc Aplysia californica. We cloned the AstC precursor from the cDNA of Aplysia. We predicted a 15-amino acid peptide with a disulfide bridge, i.e., AstC, using NeuroPred. We then cloned two putative allatostatin C-like receptors and through NCBI Conserved Domain Search we found that they belonged to the G protein-coupled receptor (GPCR) family. In addition, using an inositol monophosphate 1 (IP1) accumulation assay, we showed that Aplysia AstC could activate one of the putative receptors, i.e., the AstC-R, at the lowest EC50, and AstC without the disulfide bridge (AstC') activated AstC-R with the highest EC50. Moreover, four molluscan AstCs with variations of sequences from Aplysia AstC but with the disulfide bridge activated AstC-R at intermediate EC50. In summary, our successful identification of the Aplysia AstC precursor and its receptor (AstC-R) represents the first example in molluscs, and provides an important basis for further studies of the AstC signaling system in Aplysia and other molluscs.
- 24 January 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-13
Open AccessIdentification of an allatostatin C signaling system in mollusc Aplysia
Neuropeptides, as pervasive intercellular signaling molecules in the CNS, modulate a variety of behavioral systems in both protostomes and deuterostomes. Allatostatins are neuropeptides in arthropods that inhibit the biosynthesis of juvenile hormones. Based on amino acid sequences, they are divided into three different types in arthropods: allatostatin A, allatostatin B, allatostatin C. Allatostatin C (AstC) was first isolated from Manduca sexta, and it has an important conserved feature of a disulfide bridge formed by two cysteine residues. Moreover, AstC appears to be the ortholog of mammalian somatostatin, and it has functions in common with somatostatin, such as modulating feeding behaviors. The AstC signaling system has been widely studied in arthropods, but minimally studied in molluscs. In this study, we seek to identify the AstC signaling system in the marine mollusc Aplysia californica. We cloned the AstC precursor from the cDNA of Aplysia. We predicted a 15-amino acid peptide with a disulfide bridge, i.e., AstC, using NeuroPred. We then cloned two putative allatostatin C-like receptors and through NCBI Conserved Domain Search we found that they belonged to the G protein-coupled receptor (GPCR) family. In addition, using an inositol monophosphate 1 (IP1) accumulation assay, we showed that Aplysia AstC could activate one of the putative receptors, i.e., the AstC-R, at the lowest EC50, and AstC without the disulfide bridge (AstC') activated AstC-R with the highest EC50. Moreover, four molluscan AstCs with variations of sequences from Aplysia AstC but with the disulfide bridge activated AstC-R at intermediate EC50. In summary, our successful identification of the Aplysia AstC precursor and its receptor (AstC-R) represents the first example in molluscs, and provides an important basis for further studies of the AstC signaling system in Aplysia and other molluscs.
- Open Access
- 17 June 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (25) , eaba4856
Synaptic mechanisms for motor variability in a feedforward network
Two Aplysia command neurons drive motor programs with various levels of variability through synaptic noise and different strength.
- 17 June 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (25) , eaba4856
Open AccessSynaptic mechanisms for motor variability in a feedforward network
Two Aplysia command neurons drive motor programs with various levels of variability through synaptic noise and different strength.